Stroke and the Risk of Alzheimer Disease

Archives of Neurology

Volumn 60, Issue 12, 2003, Pages 1707-1712

  Honig, Lawrence S ^a,b   Tang, Ming Xin ^a,b   Albert, Steven ^a,b   Costa, Rosanne ^b   Luchsinger, Jose ^a,b   Manly, Jennifer ^a,b   Stern, Yaakov ^a,b   Mayeux, Richard ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; HYPERTENSION; INCIDENCE; MALE; RISK FACTORS;

EID: 0347385146     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.12.1707     Document Type: Article

References (48)

1. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153-160.
2. Breteler MM, Bots ML, Ott A, Hofman A. Risk factors for vascular disease and dementia. Haemostasis. 1998;28:167-173.
3. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
4. Nyenhuis DL, Gorelick PB. Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J Am Geriatr Soc. 1998;46:1437-1448.
5. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992;49:453-460.
6. Tsolaki M, Fountoulakis K, Chantzi E, Kazis A. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of a Greek population. Int Psychogeriatr. 1997;9:327-341.
7. Waite LM, Broe GA, Creasey H, et al. Neurodegenerative and other chronic disorders among people aged 75 years and over in the community. Med J Aust. 1997;167:429-432.
8. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9-23.
9. Leys D, Erkinjuntti T, Desmond DW, et al. Vascular dementia: the role of cerebral infarcts. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):S38-S48.
10. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813-817.
11. Treves TA, Bornstein NM, Chapman J, et al. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia. Alzheimer Ois Assoc Disord. 1996;10:189-191.
12. Prince M, Lovestone S, Cervilla J, et al. The association between APOE and dementia does not seem to be mediated by vascular factors. Neurology. 2000;54:397-402.
13. Roses AD, Saunders AM. ApoE, Alzheimer's disease, and recovery from brain stress. Ann N Y Acad Sci. 1997;826:200-212.
14. Slooter AJ, Bots ML, Havekes LM, et al. Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study. Stroke. 2001;32:1947-1952.
15. Luthra K, Prasad K, Kumar P, Dwivedi M, Pandey RM, Das N. Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study. Clin Genet. 2002;62:39-44.
16. Basun H, Corder EH, Guo Z, et al. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke. 1996;27:1310-1315.
17. MacLeod MJ, De Lange RP, Breen G, Meiklejohn D, Lemmon H, Clair DS. Lack of association between apolipoprotein E genotype and ischaemic stroke in a Scottish population. Eur J Clin Invest 2001;31:570-573.
18. Catto AJ, McCormack LJ, Mansfield MW, et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand. 2000;101:399-404.
19. Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol. 2000;57:869-874.
20. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia and cognitive function. Neurology. 2002;58:1175-1181.
21. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635-641.
22. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994;271:1004-1010.
23. Tang MX, Jacobs D, Stern Y, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429-432.
24. Gurland BJ, Wilder DE, Lantigua R, et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry. 1999;14:481-493.
25. Albert SM, Costa R, Merchant C, Small S, Jenders RA, Stern Y. Hospitalization and Alzheimer's disease: results from a community-based study. J Gerontol A Biol Sci Med Sci. 1999;54:M267-M271.
26. Folstein MF, Folestein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
27. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24:1019-1025.
28. Benton AL. The Benton Visual Retention Test. New York, NY: Psychological Corp; 1955.
29. Goodglass H, Kaplan E. Assessment of Aphasia and Related Disorders. Philadelphia, Pa: Lea & Febiger; 1983.
30. Benton A. FAS Test. In: Spreen O, Benton A, eds. Neurosensory Center Comprehensive Examination for Aphasia. Victoria, British Columbia: University of Victoria; 1967.
31. Weschler D. WAIS-R Manual. New York, NY: Psychological Corp; 1981.
32. Mattis S. Mental Status Examination for Organic Mental Syndrome in the Elderly Patient. New York, NY: Grune & Stratton; 1976.
33. Rosen WG. The Rosen Drawing Test. Odessa, Fla: Psychological Assessment Resources; 1981.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
36. Moroney JT, Tang MX, Berglund L, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA. 1999;282:254-260.
37. US Bureau of the Census. 1990 Census of population and housing: summary tape file 1, technical documentation (computer diskette STF 1A database). Washington, DC: 1991.
38. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31:545-548.
39. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254-259.
40. Hatano S. Experience from a multicentre stroke register; a preliminary report. Bull World Health Organ. 1976;54:541-553.
41. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776-782.
42. Kokmen E, Beard CM, Offord KP, Kurland LT. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology. 1989;39:773-776.
43. Irina A, Seppo H, Arto M, Paavo R Sr, Hilkka S. Beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients. Stroke. 1999;30:613-618.
44. Tan ZS, Seshadri S, Beiser A, et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003;163:1053-1057.
45. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke. 1997;28:316-321.
46. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483.
47. Curb JD, Rodriguez BL, Abbott RD, et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 1999;52:971-975.
48. Massoud F, Devi G, Stern Y, et al. A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol. 1999;56:1368-1373.